MedPath

MOXIFLOXACIN

MOXIFLOXACIN OPTH SOLN 0.5% 3ML

Approved
Approval ID

d9b6a460-6377-76d0-e053-2995a90a3d05

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 8, 2022

Manufacturers
FDA

Direct Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MOXIFLOXACIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72189-334
Application NumberANDA202916
Product Classification
M
Marketing Category
C73584
G
Generic Name
MOXIFLOXACIN
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMarch 8, 2022
FDA Product Classification

INGREDIENTS (6)

BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
MOXIFLOXACIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: C53598599T
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFLOXACIN - FDA Drug Approval Details